Tertomotide is a synthetic peptide vaccine, containing 16 amino acid residues (611-626) of the human telomerase reverse transcriptase catalytic subunit (hTERT), with potential antineoplastic activity. Telomerase, a reverse transcriptase normally repressed in healthy cells, is overexpressed in most cancer cells and plays a key role in cellular proliferation. Vaccination with tertomotide may activate the immune system to mount a cytotoxic T-lymphocyte (CTL) response against telomerase-expressing cells. The directory classifies it as a under development API with a peptide source/manufacturing origin. Other names for this substance include tertomotidum and PrimoVax. Its PubChem CID is 56843375.
Tertomotide
| CAS No | 915019-08-8 |
|---|---|
| Molecular Formula | C85H146N26O21 |
| Molecular Weight | 1868.2 g/mol |
| Synonyms | (2S)-6-amino-2-[[(2S)-1-[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-carboxybutanoyl]amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]propanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-phenylpropanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbonyl]amino]hexanoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Tertomotide is a synthetic peptide vaccine, containing 16 amino acid residues (611-626) of the human telomerase reverse transcriptase catalytic subunit (hTERT), with potential antineoplastic activity.
The listed CAS number is 915019-08-8.
The listed molecular formula is C85H146N26O21.
The listed molecular weight is 1868.2 g/mol.
The source lists tertomotidum and PrimoVax.
It is listed as a under development API with a peptide origin.